Company patents
ThermoLife International, LLC
ThermoLife International, LLC's patent strategy is overwhelmingly concentrated in Pharmaceutical Preparations, representing 98.9% of its portfolio, with an astonishing 210.5% growth in 2026 so far, indicating a massive surge in pharma innovation. While Therapeutic Activity (Pharma) patents have seen a decline of 20.0% in 2026, the company is rapidly expanding its focus on specific chemical structures, with Acyclic / Carbocyclic Compounds growing by 350.0% and Heterocyclic Compounds (Pharma) by 390.9% in 2026, suggesting a deep dive into novel compound development within its core pharmaceutical domain.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
95 US filings (since 2023) · 7 categories · 2 themes
Delivery systems specifically engineered to administer advanced drug formulations (e.g., microparticles, biologics, extended-release systems) to achieve precise targeting, controlled release kinetics, or enhanced therapeutic efficacy within the body.
Systems and devices for delivering gases, aerosols, or pressure support to the respiratory system, often including interfaces like masks and sophisticated control mechanisms for therapeutic effect or airway management.
Patents
Showing 1-10 of 163